nervous
The central nervous system (CNS), which is composed of the
brain and spinal cord, functions as the master control center
of the body. The brain has several main parts, including the
following:
• The cerebrum—the largest, upper part of the brain—controls voluntary muscles, perception, and what people commonly call “thinking.”
• The lower cerebellum controls many involuntary body
movements, such as swinging the arms while walking.
• The brain stem, which connects the brain to the spinal cord,
has a number of functions, including control of breathing,
heart rate, and blood pressure.
The spinal cord extends down from the brain stem only as far
as the lumbar region (lower back). Below this region, a bundle
of nerves called the cauda equina1 extends from the spinal cord.
As its name suggests, this bundle resembles the tail of a horse.
Bones of the cranium, bones of the vertebral column, and
three layers of tissue called meninges2 (mě-nin’jēz) surround the
brain and spinal cord, providing support and protection from
external shock. The three meninges vary in their structure and
appearance (FIGURE 20.1b, c).
Lying next to the bones is the dura mater3 (dŭ’ră mā’ter), a
tough fibrous sheath that provides a strong, yet flexible, covering for the soft organs of the CNS. It also provides a barrier
against the spread of infections from the bones. Deep to the
dura mater is the arachnoid mater4 (ă-rak’noyd mā’ter), which
contains numerous branching fibers giving the appearance of
a spider’s web. The cavities between the fibers of the arachnoid
mater are collectively called the subarachnoid space. The internal layer, which is pressed close to the spinal cord and brain, is
the pia mater5 (pī’ă mā’ter). Blood vessels on top of the pia mater
supply the CNS with blood. The walls of these blood vessels are
composed of tightly joined cells that form the blood-brain barrier, which prevents most microbes and large molecules in the blood
from entering the subarachnoid space. Thus, blood infections
do not easily spread to the CNS, but unfortunately, neither do
many common antimicrobial drugs, such as penicillin, cephalosporins, tetracyclines, and aminoglycosides, making it more
difficult to treat infections of the CNS.
Fluid leaks from the blood into the subarachnoid space
that lines the brain. This watery fluid—called cerebrospinal fluid
(CSF)—circulates throughout the subarachnoid space of both
brain and spinal cord to bathe both organs. Arachnoid villi or
arachnoid granulations, which are knoblike extensions of the
arachnoid mater, extend into a blood-filled cavity at the top of
the cranium and return CSF to the blood.
Cerebrospinal fluid acts as a shock absorber; provides
nutrients, electrolytes, and oxygen to the nervous tissues;
and removes wastes. In a medical procedure called a lumbar
puncture (spinal tap), physicians remove a sample of CSF from
the region of the subarachnoid space surrounding the cauda
equina. They insert a needle through the skin
between two of the lumbar vertebrae, through the dura mater
and subdural space, and through the arachnoid mater to reach
the CSF in the subarachnoid space.
y
The peripheral nervous system (PNS) is composed of nerves
that transfer commands from the CNS to muscles and glands
throughout the body and provide information to the CNS concerning events in the body. Cranial nerves extend from the brain
through holes in the cranial bones, and spinal nerves extend
from the spinal cord through gaps between vertebrae. Branches
of nerves often merge together to form a nerve plexus (see
Figure 20.1a).
Functionally, there are three types of nerves: Sensory nerves
primarily carry signals toward the CNS. The optic nerves from
the eyes are examples. Motor nerves carry signals from the CNS
to other organs of the body, and mixed nerves carry signals both
toward and away from the CNS.
Cells of the Nervous System
The entire nervous system is composed of two basic types of
cells—neurons and supportive cells called neuroglia. The smaller neuroglia provide a supportive scaffolding, insulation, and nutritive support and phagocytize
microbes. The cytoplasmic membrane of a neuron generates an
electrical signal called an action potential or nerve impulse.
The nucleus of a neuron lies in a region of cytoplasm called
the cell body. Outside the CNS, a collection of many neurons’ cell
bodies is called a ganglion. Two types of fingerlike cytoplasmic
processes extend from a cell body: numerous, perhaps hundreds,
of short dendrites and a longer single axon. Within the cytoplasm
of an axon, the cytoskeleton transports substances by a process
known as axonal transport. Do not confuse dendrites and axons,
which are part of individual cells (neurons), with sensory and
motor nerves, which are bundles of thousands of cells.
Bacterial meningitis involves inflammatory bacterial infection of
the meninges, commonly the pia mater and arachnoid mater
and, more rarely, the dura mater.
Signs and Symptoms
Bacterial meningitis is characterized by an increased number
of white blood cells in the CSF, sudden high fever, and intense
meningeal inflammation. The inflammation accounts for most
of the signs and symptoms: Swelling of the meninges retards
the normal flow of CSF, putting pressure on the underlying
organs. Inflammation of the cranial meninges typically produces severe headache, nausea, vomiting, pain, and in many
cases loss of various brain functions, leading to such conditions
as drowsiness, confusion, fretfulness, or irritability. Inflammation of the spinal meninges puts pressure on surrounding nerves and muscles, producing stiffness in the neck and
affecting sensory input and muscular control. When the brain
becomes infected—a condition called encephalitis—deafness,
blindness, drastic changes in the patient’s behavior, coma, or
death may result. Signs and symptoms of meningitis may rapidly develop; for example, meningococcal meningitis can kill
within six hours of the initial symptoms, allowing little time
for treatment.
A lumbar puncture reveals the normally clear CSF to be
milky in appearance because of the large number of bacteria and the increased number of white blood cells. Petechiae
(pe-tē’kē-ē)—small, dark purplish hemorrhages of blood vessels
in the skin—are sometimes present.
Pathogens and Virulence Factors
Researchers have shown that more than 50 species of bacteria
can cause meningitis. Among these are opportunistic members
of the normal microbiome, including species of Staphylococcus
(staf’i-1ō-kok’ŭs) and Streptococcus (strep-tō-kok’ŭs) as well as
Gram-negative enteric8 bacteria such as Escherichia coli (esh-ě-
rik’ē-ă ko’lī) and Klebsiella pneumoniae (kleb-sē-el’ă nū-mō’nē-ī).
However, five other species cause almost 90% of cases of bacterial meningitis. These are Neisseria meningitidis, Streptococcus
pneumoniae, Haemophilus influenzae, Listeria monocytogenes, and
Streptococcus agalactiae. All five of these bacteria have virulence
factors that allow them to resist phagocytosis and cause disease; the following sections detail these features.
Neisseria meningitidis Neisseria meningitidis (nī-se’rē-ă me-ninji’ti-dis) is one of only two species of Gram-negative cocci that
The terminal ends of axons have thousands of branches
that form junctions called synapses6 (sĭ-nap’sēz) with glands,
muscles, or other neurons. A synapse mediates transfer of a signal to a neighboring postsynaptic cell. In most synapses, there is
a synaptic cleft—an intercellular space about 40 nm wide
between the axon terminal and the postsynaptic cell. A synaptic cleft stops the transmission of electrical signals; therefore,
the signal between cells is chemical—an axon terminal releases
molecules called neurotransmitters into the synaptic cleft. A particular neurotransmitter may be stimulatory or inhibitory; that
is, it either (1) stimulates a muscle to contract, a gland to secrete,
or another neuron to carry a nerve impulse; or (2) inhibits such
activities.
Portals of Infection of the Central Nervous System
No openings allow microbial colonization of the central nervous
system; therefore, the CNS is an axenic (ā-zēn’ik) environment—
it has no normal microbiota. Pathogens may access the CNS
through breaks in the bones and meninges, through medical procedures such as spinal taps, or by traveling via axonal
transport in peripheral neurons to the CNS. Microbes carried
in the blood or lymph may penetrate the blood-brain barrier by
infecting and killing cells of the meninges, causing meningitis7
(men-in-jī’tis)—inflammation of the meninges. Some pathogens
gain access to the CNS when localized inflammation distorts
the cells of the blood-brain barrier, changing its permeability;
such change is more likely during chronic infection by many
pathogens. Circulation of cerebrospinal fluid can carry infective microbes throughout the cranial cavity and spinal column.
We will examine nervous system diseases caused by bacteria, viruses, fungi, protozoa, and prions. We begin by considering bacterial diseases.
Not only can bacteria infect cells of the nervous system, but
toxins released by bacteria growing elsewhere in the body can
also affect neurons. In the following sections, we consider disease examples of both types—leprosy, which is a disease of cells
found in the PNS, and botulism and tetanus, which involve
toxin production. However, the most common bacterial infection of the nervous system is bacterial meningitis, which we
consider next.
Bacterial meningitis involves inflammatory bacterial infection of
the meninges, commonly the pia mater and arachnoid mater
and, more rarely, the dura mater.
Signs and Symptoms
Bacterial meningitis is characterized by an increased number
of white blood cells in the CSF, sudden high fever, and intense
meningeal inflammation. The inflammation accounts for most
of the signs and symptoms: Swelling of the meninges retards
the normal flow of CSF, putting pressure on the underlying
organs. Inflammation of the cranial meninges typically produces severe headache, nausea, vomiting, pain, and in many
cases loss of various brain functions, leading to such conditions
as drowsiness, confusion, fretfulness, or irritability. Inflammation of the spinal meninges puts pressure on surrounding nerves and muscles, producing stiffness in the neck and
affecting sensory input and muscular control. When the brain
becomes infected—a condition called encephalitis—deafness,
blindness, drastic changes in the patient’s behavior, coma, or
death may result. Signs and symptoms of meningitis may rapidly develop; for example, meningococcal meningitis can kill
within six hours of the initial symptoms, allowing little time
for treatment.
A lumbar puncture reveals the normally clear CSF to be
milky in appearance because of the large number of bacteria and the increased number of white blood cells. Petechiae
(pe-tē’kē-ē)—small, dark purplish hemorrhages of blood vessels
in the skin—are sometimes present.
Pathogens and Virulence Factors
Researchers have shown that more than 50 species of bacteria
can cause meningitis. Among these are opportunistic members
of the normal microbiome, including species of Staphylococcus
(staf’i-1ō-kok’ŭs) and Streptococcus (strep-tō-kok’ŭs) as well as
Gram-negative enteric8 bacteria such as Escherichia coli (esh-ě-
rik’ē-ă ko’lī) and Klebsiella pneumoniae (kleb-sē-el’ă nū-mō’nē-ī).
However, five other species cause almost 90% of cases of bacterial meningitis. These are Neisseria meningitidis, Streptococcus
pneumoniae, Haemophilus influenzae, Listeria monocytogenes, and
Streptococcus agalactiae. All five of these bacteria have virulence
factors that allow them to resist phagocytosis and cause disease; the following sections detail these features.
Neisseria meningitidis Neisseria meningitidis (nī-se’rē-ă me-ninji’ti-dis) is one of only two species of Gram-negative cocci that regularly causes disease in humans. Researchers have identified
13 antigenic strains; strains A, B, C, and W135 cause most cases
of disease in humans. The cells of all strains of Neisseria are
nonmotile and are typically arranged as diplococci (pairs) with
their common sides flattened in a manner reminiscent of coffee
beans (FIGURE 20.2). The bacterium is known as the meningococcus and its disease as meningococcal meningitis.
Meningococci have fimbriae and polysaccharide capsules,
as well as a major cell wall antigen called lipooligosaccharide
(lĭp’ō-ŏl’ĭ-gō-sak’ă-rīd, LOS), composed of lipid A (endotoxin)
and sugar molecules—all of which enable the bacteria to
attach to human cells. Cells of Neisseria that lack any of these
three structural features are avirulent. The polysaccharide
capsules also resist lytic enzymes of the body’s phagocytes,
allowing phagocytized meningococci to survive, reproduce,
and be carried throughout the body within neutrophils and
macrophages.
Much of the damage caused by N. meningitidis results from
blebbing—a process in which the bacterium sheds extrusions
of its outer membrane. The lipid A component of LOS thereby
released into the body triggers fever, vasodilation, inflammation, shock, and widespread blood clotting.
Streptococcus pneumoniae Louis Pasteur discovered Streptococcus pneumoniae (strep-tō-kok’us nū-mō’nē-ī) in pneumonia
patients about 120 years ago. The bacterium is an encapsulated Gram-positive coccus, which forms short chains or, more
throat that opportunistically grow in the lungs, sinuses, and
middle ear and from those locations move into the meninges via
the blood. Streptococcus pneumoniae is a leading cause of meningitis in children less than 5 years old and in very old adults.
Even though microbiologists have studied pneumococci
extensively, they still do not fully understand how these bacteria cause disease; nevertheless, certain structural and chemical
virulence factors are necessary for disease.
The cells of all virulent strains of S. pneumoniae are surrounded by a polysaccharide capsule, which protects them
from digestion after phagocytosis. Unencapsulated strains
do not cause disease. Pathogenic pneumococci also produce
enzymes and toxins that enable the bacteria to counteract
immune defenses.
In addition, pathogenic S. pneumoniae possess a cell wall
chemical called phosphorylcholine, which is an adhesin that
binds to receptors on cells in the lungs, the meninges, and
blood vessel walls. Binding stimulates target cells to endocyrize the bacteria. Thus, the phosphorylcholine and polysaccharide capsule together enable pneumococci to “hide” inside
body cells. S. pneumoniae can then pass across these cells into
the blood and brain.
Haemophilus influenzae Haemophilus9 influenzae (hē-mof’i-lŭs
in-flu-en’zī) is a small pleomorphic bacillus (FIGURE 20.4)
that requires heme and NAD+ for growth. As a result, it is an
obligate parasite, colonizing mucous membranes of humans
and some animals. At one time—as the specific epithet indicates—scientists thought that the bacterium caused flu pandemics in 1890 and 1918, but H. influenzae causes meningitis,
not the flu. Most strains of H. influenzae have polysaccharide
capsules that resist phagocytosis. Researchers distinguish
among six strains of Haemophilus by differences in capsular antigens. Before the introduction of an effective vaccine in the
1990s, 95% of H. influenzae diseases in the United States were
caused by type b.
Listeria monocytogenes Listeria monocytogenes (lis-tēr’ē-ă mo-nō-
sī-to’je-nēz) is a Gram-positive, non-endospore-forming coccobacillus that enters the body in contaminated food or drink.
Listeria is rarely pathogenic in healthy adults; infection in pregnant women, fetuses, newborns, the elderly, and immunocompromised patients can result in meningitis.
Disease in Depth on pp. 602–603 examines listeriosis,
including meningitis caused by Listeria, in detail.
Streptococcus agalactiae Streptococcus agalactiae (strep-tō-kok’ŭs
a-ga-lak’tē-ī), also known as Lancefield10 group B Streptococcus
(based on its so-called B antigen), is a normal member of the
vaginal microbiota in about a third of all women. The bacterium
produces a protective capsule that allows it to evade phagocytosis when it gets into the blood. S. agalactiae also causes bacteremia, pneumonia, and meningitis in newborns.
Pathogenesis
Humans inhale N. meningitidis, H. influenzae, and S. pneumoniae
in respiratory droplets from infected individuals (who may
appear healthy). Babies pick up S. agalactiae during passage
through an infected birth canal. Listeria is transmitted in contaminated food, particularly meat and underpasteurized milk
and cheese.
In most cases, bacteria spread to the meninges from infections of the lungs, sinuses (sinusitis), or inner ear (otitis media)
via the blood (bacteremia). Head or neck surgery or trauma may
also open a passage into the subarachnoid space of the meninges. The bacteria, somewhat protected by their capsules from
phagocytosis, metabolize glucose in the CSF.
Epidemiology
Before the 1990s, H. influenzae was a leading cause of bacterial
meningitis. An effective childhood vaccine has reduced the
number of such cases by more than 90%. Today, S. pneumoniae (pneumococcus) and N. meningitidis (meningococcus) are more
prevalent causes of bacterial meningitis, though S. agalactiae is a
leading cause of bacterial meningitis in newborns in the United
States and the United Kingdom.
S. pneumoniae grows in the mouths and throats of 75% of
humans without causing harm; but in some patients, particularly children and the elderly—groups whose immune
responses are not fully active—these pneumococci become
bloodborne and invade the meninges.
None of the forms of bacterial meningitis are typically
spread by casual contact, though N. meningitidis can be spread
via respiratory droplets to other people who have prolonged
contact with a carrier. Meningoccoccal meningitis is the only
type of bacterial meningitis that becomes epidemic, particularly in sub-Saharan Africa, where massive epidemics occurred
every 5–12 years during the dry season (December to June). For
example, in the sub-Saharan nations in 2009, there were almost
90,000 cases. In 2014, as a result of mass immunization efforts
in 19 of the 26 African countries most at risk, there were only
11,908 cases.
In the United States, meningococcal meningitis is spread
among military personnel in barracks and students in dormitories. In fact, meningococcal disease is 9–23 times more
prevalent in students living in dormitories than in the general
population. Mortality of meningococcal meningitis approaches
100% in untreated patients, but is about 11% in patients who
have been treated appropriately with antimicrobial drugs.
Infant mortality from S. agalactiae meningitis has been
reduced to about 5% as a result of rapid diagnosis and supportive care, though about 25% of infants surviving this group B
streptococcal meningitis have permanent neurological damage,
including blindness, deafness, or severe mental retardation.
Listeria infects humans who consume contaminated food.
Human-to-human transmission of Listeria is limited to the transfer of bacteria from mother to fetus and can result in premature
delivery, miscarriage, stillbirth, or meningitis in the newborn.
Diagnosis, Treatment, and Prevention
Symptoms of meningitis should always be considered serious,
and a patient should consult a physician immediately. Quick
diagnosis is vital. Diagnosis of bacterial meningitis is based on
symptoms and culturing bacteria from CSF following a lumbar
puncture. Additionally, serological tests can demonstrate the
presence of antibodies against N. meningitidis, though strain
B of this species is relatively nonimmunogenic and therefore
often not revealed by such tests.
Physicians treat bacterial meningitis with any of a number
of intravenously administered antimicrobial drugs, typically
vancomycin plus ceftriaxone, cefotaxime, meropenem, or ampicillin, depending on the age and health of the patient and the
bacterium causing the meningitis. Quick treatment reduces the
mortality to below 15% of cases of bacterial meningitis.
Prevention of bacterial meningitis depends on interrupting
the transmission of pathogens and their spread in the body. The
U.S. Centers for Disease Control and Prevention (CDC) recommends vaccination of children against Streptococcus pneumoniae,
Haemophilus influenzae type B (Hib), and Neisseria meningitidis
(see Chapter 17, Figure 17.3) and administration of penicillin
at birth to any child whose mother’s vagina is colonized with
Streptococcus agalactiae (group B Streptococcus). Implementation
of the latter recommendation in 1996 reduced neonatal meningitis by 70% within five years. Additionally, health care providers
prevent the spread of group B streptococcal infection to babies
by treating infected pregnant mothers with penicillin or ampicillin, or with vancomycin for patients with penicillin allergy.
The CDC also recommends meningococcal vaccination for
all military recruits and college freshmen. Health care providers administer antimicrobials such as cirpofloxacin, ceftriaxone,
or rifampin to people in prolonged contact with meningococcal
patients. Such prophylactic treatment is not recommended following exposure to meningitis caused by other microbes.
Coxsackie, New York, where the virus was first isolated), coxsackie B virus, and echovirus.
16 (Other viruses, called arboviruses,
may also affect the meninges, but their primary target is nerve
cells. These viruses are considered in a later section.)
Pathogenesis
Enteroviruses primarily attack cells lining the intestinal tract
and lungs, in the latter case producing colds. The viruses are
cytolytic—they kill their target cells. Damage to cells in the
meninges triggers meningitis.
The incubation period of enterovirus infections is between
three and seven days, and patients recover completely without
treatment after another seven to ten days.
Epidemiology
Viral meningitis appears to be much more common than bacterial or fungal meningitis, but viral meningitis is often mild, and
the disease is not reportable, so firm data are not available.
Enteroviruses are contagious, being spread in respiratory
droplets and in feces—patients shed viruses in their feces for
weeks. For some reason, enteroviruses are more commonly
spread in the summer and early fall. The viruses are stable and
can survive in chlorinated swimming pools.
Exposure to a patient with meningitis may result in an
infection resembling a cold but rarely causes meningitis—fewer
than one of every 1000 infected people develop viral meningitis. Patients become contagious when symptoms develop and
remain contagious for up to 10 days.
Diagnosis, Treatment, and Prevention
Physicians diagnose viral meningitis based on the characteristic signs and symptoms in the absence of bacteria in CSF
obtained with a spinal tap.
No specific treatment exists for viral meningitis; health
care providers recommend resting, drinking plenty of fluids,
and taking medicine to reduce fever and headache pain.
It is difficult to suppress the spread of enteroviruses
because most infected people lack signs or symptoms. Frequent
hand antisepsis, avoiding crowded swimming pools, and
refraining from bringing contaminated hands near the mouth,
nose, or eyes limit the chance of infection.
Viral Diseases of the Nervous System
Viruses, being smaller than cells, can more readily cross the
blood-brain barrier; therefore, it is not surprising that there
are more viral infections of the nervous system than bacterial
or fungal infections. Many viruses that attack other body systems can also affect the brain: herpes and chickenpox viruses
may remain dormant in nerve cells for years, and measles virus
causes subacute sclerosing panencephalitis, which is a slow progressive's disease of the CNS. (Chapter 19 dealt with these pathogens, which primarily affect the skin.)
In the following sections we consider viruses that primarily
affect the nervous system, causing meningitis, polio, rabies, and
encephalitis. We begin our survey by considering viral meningitis.
Viral Meningitis
Signs and Symptoms
Viral meningitis is usually a milder disease than either bacterial
or fungal meningitis; although the signs and symptoms—fever,
severe headache, stiff neck, drowsiness, confusion, nausea, and
vomiting—may be the same, death from viral meningitis is rare.
Some meningitis viruses also cause skin rashes, sore throats,
and colds.
Pathogens and Virulence Factors
Herpesviruses, mumps virus, and several other viruses may
cause viral meningitis, but about 90% of cases result from infections of viruses in the genus Enterovirus14 of the family Picornaviridae.
15 As their name indicates, picornaviruses are very small
(20–30 nm in diameter), positive, single-stranded RNA
(+ssRNA) viruses. They lack envelopes. Enteroviruses are so
named because they often spread from person to person via
fecal contamination of food, water, or hands. Though ingested
enteroviruses attack cells lining the intestinal tract, they do not
cause gastrointestinal illnesses; instead, enteroviruses spread
via the bloodstream—a condition called viremia—to infect
other organs, including the meninges.
The common names for the three types of enterovirus that
cause most human meningitis are coxsackie A virus (named for Coxsackie, New York, where the virus was first isolated), coxsackie B virus, and echovirus.
16 (Other viruses, called arboviruses,
may also affect the meninges, but their primary target is nerve
cells. These viruses are considered in a later section.)
Pathogenesis
Enteroviruses primarily attack cells lining the intestinal tract
and lungs, in the latter case producing colds. The viruses are
cytolytic—they kill their target cells. Damage to cells in the
meninges triggers meningitis.
The incubation period of enterovirus infections is between
three and seven days, and patients recover completely without
treatment after another seven to ten days.
Epidemiology
Viral meningitis appears to be much more common than bacterial or fungal meningitis, but viral meningitis is often mild, and
the disease is not reportable, so firm data are not available.
Enteroviruses are contagious, being spread in respiratory
droplets and in feces—patients shed viruses in their feces for
weeks. For some reason, enteroviruses are more commonly
spread in the summer and early fall. The viruses are stable and
can survive in chlorinated swimming pools.
Exposure to a patient with meningitis may result in an
infection resembling a cold but rarely causes meningitis—fewer
than one of every 1000 infected people develop viral meningitis. Patients become contagious when symptoms develop and
remain contagious for up to 10 days.
Diagnosis, Treatment, and Prevention
Physicians diagnose viral meningitis based on the characteristic signs and symptoms in the absence of bacteria in CSF
obtained with a spinal tap.
No specific treatment exists for viral meningitis; health
care providers recommend resting, drinking plenty of fluids,
and taking medicine to reduce fever and headache pain.
It is difficult to suppress the spread of enteroviruses
because most infected people lack signs or symptoms. Frequent
hand antisepsis, avoiding crowded swimming pools, and
refraining from bringing contaminated hands near the mouth,
nose, or eyes limit the chance of infection.
poliomyelitis
Signs and Symptoms
After being ingested and infecting pharyngeal and intestinal
cells, poliovirus travels via the lymph and blood to infect cells
of the CNS, particularly of the spinal cord. It causes one of the
following four conditions:
• Asymptomatic infections account for about 90% of all cases.
• Minor polio includes nonspecific symptoms such as temporary fever, headache, malaise, and sore throat. Approximately 5% of cases are minor polio. • Nonparalytic polio results from polioviruses invading the
meninges and central nervous system, producing muscle
spasms and back pain in addition to the general symptoms of
minor polio. Nonparalytic polio occurs in about 2% of cases.
• Paralytic polio involves viral invasion of cells of the spinal
cord and the portion of the cerebrum that controls skeletal
muscles, producing paralysis by limiting nerve impulse
conduction. The degree of paralysis varies with the strain
of poliovirus involved, the infective dose, and the health
and age of the patient. In a type of paralytic polio called
bulbar poliomyelitis, the brain stem is infected, resulting in
paralysis of respiratory muscles or of muscles in the limbs
(see Disease at a Glance 20.3). In the past, iron lungs were
used to help victims breathe. In most paralytic cases, complete recovery results after 6–24 months, but in some cases
paralysis is lifelong. Paralytic polio occurs in fewer than
2% of infections.
Postpolio syndrome is a crippling deterioration in the function of polio-affected muscles that occurs in up to 80% of recovered polio patients some 30–40 years after their original bout
with poliomyelitis. This condition is not caused by a reemergence of polioviruses, because viruses are not present. Instead,
the effects appear to stem from an aging-related aggravation of
nerve damage that occurred during the original infection.
Pathogen and Pathogenesis
Poliovirus is another species of Enterovirus (family Picornaviridae). Poliovirus is relatively stable outside the body and remains
infectious in food and water for some time. Scientists distinguish three strains of poliovirus by their antigens. Each of the
three can cause all types of polio.
People most often get poliovirus by drinking contaminated
water. The viruses are replicated in cells of the throat and small
intestine, producing initial symptoms of sore throat and nausea. Viruses then infect lymph nodes and from there enter the
blood. In most people, the infection ends there; however, viremia may progress to infection of neurons of the CNS. Paralysis develops following destruction of motor neurons in the upper
spinal cord and brain stem; poliovirus does not infect muscles.
Epidemiology
The near elimination of polio stands as one of the great achievements of 20th-century medicine. Soon, like smallpox virus,
poliovirus will exist only in laboratories.
The last case of naturally occurring poliomyelitis in
the Americas occurred in 1979. A milestone was reached in
2014 when the World Health Organization (WHO) declared
Southeast Asia, including India, polio free. Worldwide, the number of naturally acquired polio cases dropped from 350,000 in
1988 to a low of only 74 in 2015. Additionally, there were 32 cases
of vaccine-derived polio. Polio currently exists endemically only
in Pakistan and Nigeria, though there was a quickly contained
reemergence in Nigeria in 2016 (see Figure 20.10).
Diagnosis, Treatment, and Prevention
Diagnosis of polio is based upon demonstration of the virus
in throat secretions or feces. There is no specific treatment for
polio besides managing the symptoms of infection.
Two effective vaccines make polio eradication possible.
Jonas Salk (1914–1995) developed an inactivated polio vaccine
(IPV) in 1955. Later, it was replaced by a live, attenuated (weakened), oral polio vaccine (OPV) developed by Albert Sabin
(1906–1993). Both vaccines are effective in providing immunity
against all three strains of poliovirus. Healthcare workers have
returned to using IPV because the attenuated viruses in OPV
occasionally mutate into virulent viruses that cause cases of
vaccine-derived polio. TABLE 20.1 compares the advantages
and disadvantages of the two vaccines.
Disease at a Glance 20.3 summarizes the characteristics of
polio.
rabies
Signs and Symptoms
Initial signs and symptoms of rabies include pain or itching at
the site of infection, fever, headache, malaise, and anorexia.
Once the virus reaches the central nervous system, neurological manifestations characteristic of rabies develop: hydrophobia18 (triggered by the pain involved in attempts to swallow
water), seizures, disorientation, hallucinations, and paralysis.
Death results from respiratory paralysis and other neurological
complications.
Pathogen and Virulence Factors
Rabies virus is a negative, single-stranded RNA (@ssRNA)
virus in the genus Lyssavirus, family Rhabdoviridae.
Rhabdoviruses have helical capsids supercoiled into cylinders,
which give them a striated appearance, and are surrounded
by bullet-shaped envelopes (see Disease at a Glance 20.4).
Glycoprotein spikes on the surface of the envelope serve as
attachment proteins.
Pathogenesis
Rabies virus attaches to skeletal muscle cells, triggering its own
endocytosis. The virus replicates in the cytoplasm of muscle
cells. Later, it moves across neuromuscular junctions into neurons and then travels to the central nervous system via axonal
transport.
Function of the spinal cord and brain degenerate as a result
of infection, though infected cells show little structural damage when examined microscopically. Viruses travel back to
the periphery, including the salivary glands, through cranial
and spinal nerve cells. Viruses are secreted in the saliva of
infected mammals. Transmission of rabies viruses in the saliva
of infected animals usually occurs via a bite but can occur
through the introduction of viruses into breaks in the skin or
mucous membranes or, rarely, through inhalation.
Epidemiology
Rabies is a zoonosis, that is, a disease spread from animal reservoirs to humans. Rabies affects mammals, though not all
mammals are reservoirs; rodents, for instance, rarely get rabies.
The main mammals involved differ from locale to locale and
change over time as a result of changes in animal populations
and interactions among animals and humans. The primary reservoir of rabies in urban areas is the dog. In the wild, rabies
can be found in many animals, including foxes, badgers, raccoons, skunks, cats, bats, and feral dogs (FIGURE 20.11). Bats
are the source of most cases of rabies in humans, causing about
75% of cases. Only one case of rabies in humans occurred in the
United States in 2015.
Diagnosis, Treatment, and Prevention
The neurological symptoms of rabies are unique and generally
sufficient for diagnosis. Tests for antibodies in the blood confirm the diagnosis. Postmortem laboratory tests are often conducted to determine whether a suspected animal in fact carries
rabies virus. These tests include antigen detection by immunofluorescence and the identification of aggregates of viruses
(called Negri bodies) in the brain (FIGURE 20.12). Unfortunately, by the time symptoms appear and antibody production
occurs, it is too late to intervene, and the disease will follow its
natural course.
Human rabies vaccine, which is called human diploid cell
vaccine (HDCV), is prepared from deactivated rabies viruses
cultured in human diploid cells. It is administered intramuscularly on days 0, 3, 7, and 14 after exposure to rabies virus. The
vaccine can also be administered before infection to workers
who regularly come into contact with animals (veterinarians, zookeepers, and animal control workers) and to people traveling to areas of the world where rabies is prevalent.
Treatment of rabies begins with treatment of the site of
infection. The wound should be thoroughly cleansed with
water and soap or another substance that deactivates viruses.
The World Health Organization recommends anointing the
wound with antirabies serum. Initial treatment also involves
injection of human rabies immunoglobulin (HRIG). Subsequent
treatment involves the four vaccine (HDCV) injections, mentioned previously. Rabies is one of the few infections that
can be treated with active immunization because the progress
of viral replication and movement to the brain is slow enough
to allow effective immunity to develop before disease develops.
The control of rabies involves immunization of domestic
dogs and cats and the removal of unwanted strays from urban
areas. It is more difficult to eliminate rabies in wild animals
because rabies virus can infect so many species, though in the
late 1990s an epidemic of rabies was stopped in southern Texas
by the successful immunization of the wild coyote population.
This was accomplished by lacing meat with an oral vaccine and
dropping it from airplanes into the coyotes’ range.
arboviral encephalitis
Signs and Symptoms
Most mosquito-borne arboviruses cause only mild, coldlike
symptoms in humans within three to seven days of infection.
Occasionally arboviruses in the blood cross the blood-brain
barrier to cause arboviral encephalitis, which is characterized by signs and symptoms similar to those of meningitis:
high fever, weakness, nausea, vomiting, abrupt headache, and
changes in mental state such as confusion, disorientation, and
coma. Some patients report body aches and develop a skin rash.
Neurological effects may be permanent.
Humans are not the only victims. Arboviruses also attack
birds, horses, chimpanzees, cats, dogs, chipmunks, and even
alligators. (Scientists are not sure how thick-skinned gators contract the disease.)
Pathogens
Six arboviruses cause most cases of viral encephalitis in Americans. Scientists name these viruses for the geographic regions
where the diseases or viruses were first identified. The diseases
and their viruses are:
• Eastern equine encephalitis (EEE), Western equine encephalitis (WEE), and Venezuelan equine encephalitis (VEE), all
of which were first identified in horses in the eastern United
States, western United States, and Venezuela, respectively.
The viruses causing these conditions are all enveloped,
+ssRNA viruses in the family Togaviridae (FIGURE 20.13).
• St. Louis encephalitis and West Nile encephalitis, which
were first identified in St. Louis, Missouri, and West Nile
Province, Uganda (Africa), respectively. Their enveloped,
+ssRNA viruses are in the family Flaviviridae; they differ
from togaviruses in their antigens. West Nile virus (WNV),
which arrived in the United States in 1999, has had the
most impact on people in the United States.
• California (also known as LaCrosse) encephalitis, which
is endemic to California but was first described from
LaCrosse, Wisconsin. The virus, which is enveloped and has
a segmented @ssRNA genome, is in the family Bunyaviridae.
Physicians are concerned that new forms of viral encephalitis
have appeared in Asia and Australia.
Pathogenesis
female Aedes or Culex mosquitoes carry the viruses among infected hosts. Mosquitoes remain
infected with arboviruses, which they pass to their offspring in eggs; mothers and their female young are a continual source of
new infections. Viruses overwinter in eggs or hibernating mosquitoes. Researchers have demonstrated that West Nile virus
and other arboviruses can be transmitted between people via
blood transfusion and transplanted organs.
Arboviruses enter target cells via endocytosis and replicate
within them. They produce viremia and can cross the bloodbrain barrier by an unknown mechanism to cause encephalitis.
In horses and humans, viruses are released from infected cells
into the blood (viremia), but the concentration of viruses in
their blood is never high enough to infect mosquitoes, so horses
and humans are “dead-end” hosts for arboviruses.
Most patients experience severe flulike symptoms but survive, though 50% of patients still suffer a year later with headaches, cognitive and memory impairment, fatigue, tremors, or
depression. Mortality ranges from less than 1% with California
encephalitis to 35% with EEE, which is the most severe arboviral encephalitis in people.
Epidemiology
The normal host for encephalitis arboviruses is either a bird
(viruses of EEE, WEE, St. Louis encephalitis, and West Nile
encephalitis) or a rodent (viruses of VEE and California encephalitis). People who engage in work or recreation outdoors in
endemic areas are at risk of accidental infection, and those
older than 50 are at a higher risk of contracting EEE, St. Louis
encephalitis, and West Nile encephalitis. Children are at higher
risk for WEE, VEE, and California encephalitis.
As their names suggest, EEE, WEE, and VEE are typically
limited to the eastern United States, western United States, and
South and Central America, respectively. California encephalitis has been reported in most states west of the Mississippi
River; St. Louis and West Nile viral infections occur in the
lower continental 48 states.
The incidence of all types of arboviral encephalitis in the
United States is seasonal, with peaks that correspond to the
times of the year during which adult mosquitoes are active.
For example, FIGURE 20.15 illustrates the seasonal nature of
reported cases of encephalitis caused by West Nile virus. Birds
spread many types of arboviruses rapidly through an environment. This was dramatically demonstrated by the spread of
West Nile virus from New York City in 1999 across the continent
in just four years. Species of Culex mosquito and 300 species of
birds transmit and harbor WNV. House sparrows are an important bird reservoir—they don’t die when infected, and their huge
population means they outnumber all other bird carriers.
TABLE 20.2 (p. 617) summarizes the distribution, vectors,
hosts, and epidemiology of arboviral encephalitis in the United
States.
Diagnosis, Treatment, and Prevention
Diagnosis of human arboviral encephalitis is based upon observation of signs and symptoms followed by a positive laboratory
test for antibodies against specific arboviruses in the CSF. A commonly used laboratory test measures the concentration of IgM, the
antibody class produced early in an infection. The test is positive
in most infected people within eight days of onset of symptoms. As with viral meningitis, treatment for arboviral encephalitis
is supportive: possible hospitalization, administration of intravenous fluids, respiratory support (ventilator), prevention of secondary infections—in other words, good nursing care. Such treatment
for a prolonged, serious case of WEE can cost nearly $3 million!
Human disease is prevented by limiting contact with
mosquitoes—through the use of netting and insect repellent containing DEET (N,N-diethyl-m-toluamide)—and by reducing mosquito numbers through the elimination of stagnant water, which
is a common breeding site for Culex, and the use of insecticides.
Veterinarians can administer effective vaccines against
EEE, WEE, VEE, and WNV to horses, but the U.S. Food and
Drug Administration (FDA) has not approved human vaccines.
Scientists have developed an effective human vaccine against
West Nile virus; safety trials are ongoing.
cryptococcal meningitis
Cryptococcal meningitis (cryptococcosis) affects people worldwide. Unlike other forms of fungal meningitis, it affects healthy
people as well as those who are sick or immunocompromised.
Signs and Symptoms
Cryptococcal meningitis manifests with signs and symptoms
common to bacterial meningitis: headache, dizziness, drowsiness, irritability, confusion, nausea, vomiting, and neck stiffness. In late stages of the disease, loss of vision and coma occur.
Acute onset of rapidly fatal cryptococcal meningitis occurs in
individuals with widespread infection. Pathogen and Virulence Factors
Cryptococcus neoformans is a basidiomycete yeast; that is, it is a
spherical, single-celled fungus that reproduces sexually with
basidiospores. It lives in soil, the feces of birds, and the sap of
eucalyptus trees.
Scientists recognize two variants of the yeast, both of which
are found worldwide. C. neoformans var. gattii primarily infects
immunocompetent individuals, whereas C. neoformans var. neoformans predominantly infects immunocompromised hosts.
Approximately 50% of all cryptococcal infections reported each
year are due to the latter variant.
The polysaccharide capsule that surrounds each cryptococcal cell is resistant to phagocytosis by defensive cells of the
body. The pathogenesis of Cryptococcus is also enhanced by
the ability of the yeast to produce melanin, which appears to
inhibit phagocytic killing mechanisms. The yeast has a predilection for the central nervous system.
Pathogenesis and Epidemiology
Human infections begin in the lungs following inhalation of
spores and/or dried yeast cells made airborne when bird droppings containing the fungus are disturbed by the activities of
the birds or humans. People who work around buildings where
birds roost are at increased risk of infection. In most individuals, phagocytes in the lungs limit spread of the yeast, but in
some patients, the fungus spreads via the blood throughout the
body. It infects both meninges and brain tissue.
Before the advent of AIDS, there were fewer than 500 infections annually worldwide. Now, terminal AIDS patients (who
have little immune function remaining) account for almost a
million cryptococcal infections each year globally, and about
625,000 die.
Diagnosis, Treatment, and Prevention
The preferred method of confirming cryptococcal meningitis is
detection of fungal antigen in CSF. In AIDS patients, antigen
can be detected in serum as well. Fungal stains revealing the
presence of encapsulated yeast in CSF are highly suggestive
of cryptococcal meningitis, even if no obvious symptoms are
present.
Treatment is with intravenous amphotericin B and oral
5-fluorocytosine administered together for at least four weeks.
The two drugs enhance one another, allowing lower doses of
amphotericin B, which is toxic to humans, to be used; however,
toxicity is not eliminated. Though AIDS patients may appear
well following primary treatment, the fungus typically remains
and must be actively suppressed by lifelong oral fluconazole
treatment.
Because the fungus is a threat to sick individuals, facilities
such as hospitals and nursing homes often place devices that
deter the roosting of birds near outside air-intake vents in an
effort to prevent Cryptococcus-contaminated air from entering
the building. No vaccine against Cryptococcus is available.
Disease at a Glance 20.6 summarizes the features of cryptococcal infection.
Having examined bacterial, viral, and fungal neurological
diseases, we turn our attention to representative diseases of the
nervous system caused by protozoa.
variant creutz-jakob disease
Signs and Symptoms
In vCJD, brain tissue is destroyed, and numerous cavities form
(see Disease at a Glance 20.7 on p. 623). As the brain deteriorates, victims experience insomnia, weight loss, and memory
failure. They also act irrationally, lose control of their muscles, and are unable to speak, walk, or maintain posture. Muscle
spasms progressively worsen as the disease progresses. Death
usually occurs within 12 months.
Pathogen, Pathogenesis, and Epidemiology
A prion protein causes vCJD. Prions exist in one of two
three-dimensional forms (see Figure 13.22): The normal form
is anchored in lipid rafts in membranes of neurons of the CNS
and is necessary for normal brain function, though scientists
don’t understand its exact role. An abnormal prion acts as an
enzyme to refold the normal form into a copy of the abnormal
form. Newly misfolded prions then proceed to make copies of
themselves from surrounding normal prion molecules. In other
words, abnormal prions turn normal prion proteins into abnormal prions, which continue the process. The disease progresses
unrelentingly, destroying the brain as it does.
Medical procedures such as transplants, blood transfusion
from an infected person, use of contaminated surgical instruments, and injection of growth hormones derived from infected
pituitary glands can spread the disease. Prions may remain
dormant for more than 60 years.
Unlike the genetic form of CJD, variant CJD strikes even
young people who consume contaminated nerve tissue, typically in meat products such as sausages. Since its discovery in
1996, vCJD has killed about 225 people. Studies suggest that 1 in
2000 people in the United Kingdom are infected with the abnormal prion; thousands of British people wonder whether they
have been infected and will succumb to vCJD in the future.
Diagnosis, Treatment, and Prevention
The characteristic signs and symptoms of vCJD are diagnostic
in the young but can be confused with other forms of dementia
in the elderly. Laboratory tests on samples from the CNS confirm the presence of abnormal prion in the brain.
No treatment is available for vCJD, though interleukins
may slow disease progression. It is difficult to destroy prions
even outside the body—prions survive cooking, freezing, pickling, and even normal autoclaving. Currently, autoclaving in a
concentrated solution of sodium hydroxide is recommended to
destroy prions, but you would not want to eat a hot dog prepared that way! The European Union but not the United States
has approved an enzyme treatment to remove prions from the
environment.
Prevention of vCJD is possible only by remaining free of
the prion by avoiding contaminated meat, particularly meat
cut from bones near the spinal cord and processed meats made
from brains or spinal cords of infected animals. As British
farmers and ranchers learned, destruction of potentially
infected sheep and cattle herds is mandatory to prevent the
spread of vCJD. Further, governments have initiated strict laws
and inspection procedures to prevent the use of contaminated
animal protein in food supplements for herbivores.
Disease at a Glance 20.7 summarizes the features of variant Creutzfeldt-Jakob disease.